phase

AB Science has received approval from several European countries to initiate the confirmatory phase 3 study of masitinib in ALS

PRESS RELEASE AB SCIENCE HAS RECEIVED APPROVAL FROM SEVERAL EUROPEAN COUNTRIES TO INITIATE THE CONFIRMATORY PHASE 3 STUDY OF MASITINIB…

3 hours ago

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+

July 22, 2025 02:00 ET  | Source: Scancell Holdings Plc SCOPE trial of SCIB1/iSCIB1+ plus standard of care shows excellent…

2 days ago

Start with $100 and Earn Daily: How AIXA Miner Opens Crypto Income to All

Denver, Colorado, July 19, 2025 (GLOBE NEWSWIRE) -- As the cryptocurrency market matures and moves into its next phase of…

5 days ago

ACES Signs Landmark Agreement with BMRCL to Build 4G/5G-Ready Neutral Host Telecom Infrastructure Across Namma Metro

BANGALORE, India, July 17, 2025 /PRNewswire/ -- ACES India Private Limited, a wholly owned subsidiary of Saudi Arabia-based Advanced Communications…

6 days ago

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity – - Full data from Phase…

2 weeks ago

Youth lead the way as Milano Cortina 2026 embodies the new Italian spirit

26 June 2025 - With less than eight months to go until the Milano Cortina 2026, the Organising Committee for the…

2 weeks ago

Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025

SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

2 weeks ago

IPO Bound Pace Digitek Limited Inaugurates BESS Manufacturing Facility in Bidadi, Karnataka

BENGALURU, India, July 3, 2025 /PRNewswire/ -- Pace Digitek Limited (Pace Digitek), an experienced multi-disciplinary solutions provider in the telecom…

3 weeks ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

3 weeks ago

Azentio appoints Harikrishnan Venkataramanan as President – ERP to spearhead next phase of innovation and growth

SINGAPORE, July 3, 2025 /PRNewswire/ -- Azentio Software ("Azentio"), a leading technology enabler in the banking, financial services, insurance (BFSI),…

3 weeks ago